Search

everythinglearnresearchcommunity

for

Search:↓

Drugs that block DHT production can effectively treat enlarged prostate and improve urinary issues with some sexual side effects.

A new score can help predict which patients might have trouble urinating after prostate surgery.

Patients follow treatment well, but many change medicines; good information helps compliance.

Finasteride affects urinary steroid profiles and can potentially hide steroid abuse in sports drug testing.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

The document highlights recent findings and treatments in urology, including prostate cancer diagnostics, urinary incontinence, and new therapies.

People with early-onset hair loss (AGA) have a higher risk of heart disease, metabolic syndrome, and prostate enlargement.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Serenoa repens is a common and effective plant-based treatment for mild-to-moderate prostate enlargement symptoms.

Prostate surgery is often effective long-term, but some patients may need more treatment or another surgery, especially if they had prostatitis before.

The Unani Pharmacopoeia-Based Formulation significantly improved symptoms of enlarged prostate in rats.

TURP specimens should be checked for various tumors, not just common prostate issues.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

Five-alpha reductase inhibitors, like finasteride and dutasteride, can treat enlarged prostates, improve urination, reduce need for prostate surgery, and lower the risk of prostate cancer, but may increase the risk of higher grade prostate cancer. They can also treat male pattern baldness.

5-alpha reductase inhibitors may have additional effects on cancer, mental health, heart health, and hormone levels beyond treating prostate enlargement.

5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.

Finasteride reduces PSA levels by around 40-50% in BPH patients.

Finasteride before TURP reduces blood loss and improves early postoperative quality of life.

There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.

Dutasteride is more effective than finasteride for treating BPH without extra safety risks.

Men with male-pattern baldness have higher levels of certain testosterone metabolites and may have more active androgen metabolism.

Castration and finasteride lower urinary oxalate in male rats, potentially treating urolithiasis.

Tamsulosin works faster, but both drugs have similar effects after 6 months.

Men with urinary symptoms are more likely to have erectile dysfunction, and there's a debate about research methods and authorship ethics.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.